Qure.ai

Qure.ai builds AI software for medical imaging and care coordination, with products that read chest X rays, head CT scans and musculoskeletal X rays and that route patients along stroke, tuberculosis and lung cancer pathways. The flagship qXR reads chest X rays and flags abnormalities associated with tuberculosis, lung cancer and other conditions as soon as the image is taken, so patients can be moved to CT or treatment sooner. It works with existing X ray hardware, new or old, which is why it is deployed in national TB screening programs as well as hospital radiology departments. The customer base spans public health programs, hospitals, teleradiology providers and pharmaceutical partners. qER supports stroke and traumatic brain injury triage across hub and spoke hospital networks; qTrack is a cloud reporting and case management platform for screening programs; qMSK reports musculoskeletal X rays; a lung nodule management product detects nodules early and measures progression; a heart failure product extends the portfolio into cardiology; and Aira is a clinical decision support system for imaging. Qure.ai cites FDA clearances and CE marks for its imaging products and partnerships with AstraZeneca, Medtronic and NHS trusts in the UK. Qure.ai does not publish pricing. Products are licensed to health systems and screening programs, and every engagement is quoted by the company.